Tomoko Maeda-Chubachi, MD, PhD, MBA
SESSIONS
U014 Dermatology Meets Pharma: Drug Development, Industry Collaborations, Career Paths
Mar 27, 2026
•
12:00 AM - 12:00 AM
•
Bluebird 2E
DISCLOSURES
Ligand Pharmaceuticals – Consultant (1099 relationship)(Fees); Meiji Seika Pharma Co., Ltd – Consultant (1099 relationship)(Fees); Pelthos Therapeutics – Consultant (1099 relationship)(Fees); SATO Pharmaceutical Co., Ltd – Consultant (1099 relationship)(Fees); TMC Clinical Development Consulting, Inc – Founder(Honoraria); TWi Biotechnology, Inc. – Consultant (1099 relationship)(Fees);